Expanding Product Line MYOS CORP has been actively launching new products tailored to muscle health and wellness for both humans and animals, including recent launches like MYOS Muscle Formula PLUS and MYOS MD. This demonstrates opportunities for sales collaboration with health and wellness retailers, veterinary clinics, and healthcare practitioners seeking innovative dietary supplements.

Strategic Partnerships The company's recent collaborations with K9 Medic and JJ Virgin highlight a focus on leveraging influential partners in the veterinary and health expert communities. Sales efforts could target similar partnership opportunities to expand distribution channels and strengthen brand presence in specialized markets.

Market Diversification MYOS CORP is diversifying into various markets including companion animals, working dogs, and horses, with products like MYOS Equine Muscle Formula and canine supplements. Exploring additional verticals such as sports nutrition, elderly care, or medical nutrition could unlock new sales opportunities.

Research-Driven Approach With its portfolio of 14 clinical studies and 12 patents, MYOS CORP emphasizes evidence-based product development. There is potential to position the company as a trusted partner with healthcare providers interested in science-backed nutritional solutions, fostering B2B collaborations or bulk sales.

Financial & Market Position Operating with revenue between $10M and $25M and recent funding rounds, MYOS CORP is positioned for growth. Sales teams could target distribution agreements with mid-sized health and wellness retailers, veterinary supply chains, and specialty distributors looking for innovative, scientifically supported products.